Loredana Bucciarelli
- Clinical Biochemistry top 0.05%
- Advanced Glycation End Products research 22
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 10
- Diabetes Treatment and Management 10
- Diabetes Management and Research 8
- Natural Antidiabetic Agents Studies 5
- Periodontics top 1%
- Nephrology top 1%
- Neurology top 5%
-
- S100 Proteins and Annexins 5
-
- Pancreatic function and diabetes 4
-
- Cardiovascular Function and Risk Factors 3
Loredana Bucciarelli
39 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 108
- Clinical Biochemistry 2.7k
- Endocrinology, Diabetes and Metabolism 1.5k
- Periodontics 305
- Nephrology 425
- Neurology 252
Countries citing papers authored by Loredana Bucciarelli
This map shows the geographic impact of Loredana Bucciarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loredana Bucciarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loredana Bucciarelli more than expected).
Fields of papers citing papers by Loredana Bucciarelli
This network shows the impact of papers produced by Loredana Bucciarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loredana Bucciarelli. The network helps show where Loredana Bucciarelli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Loredana Bucciarelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 1 | |
| 9 | 2016 | 18 | |
| 10 | 2013 | 121 | |
| 11 | 2006 | 21 | |
| 12 | 2005 | 185 | |
| 13 | 2005 | 3 | |
| 14 | 2005 | 55 | |
| 15 | 2003 | 141 | |
| 16 | 2003 | 484 | |
| 17 | Glycation and diabetes: The RAGE connection | 2002 | 41 |
| 18 | 2002 | 250 | |
| 19 | 2002 | 321 | |
| 20 | 2001 | 359 |
About Loredana Bucciarelli
Loredana Bucciarelli is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 46 papers that have together received 4.5k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (22 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Diabetes Treatment and Management (10 papers), Diabetes Management and Research (8 papers), Natural Antidiabetic Agents Studies (5 papers), S100 Proteins and Annexins (5 papers), Pancreatic function and diabetes (4 papers) and Cardiovascular Function and Risk Factors (3 papers). The work is most often cited by research in Clinical Biochemistry (2.7k citations), Endocrinology, Diabetes and Metabolism (1.5k citations) and Periodontics (305 citations). Loredana Bucciarelli has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Ann Marie Schmidt, Yan Lü, Thoralf Wendt, Wu Qu, David M. Stern, Shi Fang Yan, Ling Rong, Evanthia Lalla, Thomas Kislinger and M. Hofmann. Their work appears in journals such as Circulation, Circulation Research and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.